Catabasis Pharmaceuticals has a strong bearish signal in place, but the security is starting to look oversold. Awaiting buy signal on the 15 minute chart.
If you're bullish. Use the 15 minute chart, a have range of 4 set for confirmation of exit strategy. If you're bearish.
Use the 15 minute chart, a have range of 7 set for confirmation of short strategy. News Nov 27 - Batabasis Pharmaceuticals Reports Q3 2020 Results - Loss Per Share $0.56 (link)